scispace - formally typeset
G

Gail Wagoner

Researcher at University of Arkansas for Medical Sciences

Publications -  9
Citations -  883

Gail Wagoner is an academic researcher from University of Arkansas for Medical Sciences. The author has contributed to research in topics: Hippocampus & Interleukin 17. The author has an hindex of 8, co-authored 9 publications receiving 796 citations.

Papers
More filters
Journal ArticleDOI

Suppression of TH17 Differentiation and Autoimmunity by a Synthetic ROR Ligand

TL;DR: The data demonstrate the feasibility of targeting the orphan receptors RORα and RORγt to inhibit specifically TH17 cell differentiation and function, and indicate that this novel class of compound has potential utility in the treatment of autoimmune diseases.
Journal ArticleDOI

Exercise-induced gene expression in soleus muscle is dependent on time after spinal cord injury in rats.

TL;DR: It is concluded that BDNF and GDNF released from exercising muscle may be involved in exercise‐induced plasticity of the spinal cord and the data suggest that the lumbar spinal cord undergoes time‐dependent changes that temporarily impede the ability of the muscle to respond to exercise.
Journal ArticleDOI

Effects of Ethanol on Immune Response in the Brain: Region Specific Changes in Adolescent versus Adult Mice

TL;DR: Data indicate an age- and region-specific susceptibility to EtOH regulation of neuroinflammatory and addiction-related molecules as well as astrocyte phenotype.
Journal ArticleDOI

Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity

TL;DR: It is demonstrated that the LXR agonist T0901317 suppressed IL‐17A expression from splenocytes derived from Vα2.3/Vβ8.2 TCR transgenic mice and from MOG35–55‐immunized C57BL/6 mice, and that the development of EAE was suppressed in an experimental paradigm involving treatment of established EAE.
Journal ArticleDOI

The Synthetic Peroxisome Proliferator-Activated Receptor-γ Agonist Ciglitazone Attenuates Neuroinflammation and Accelerates Encapsulation in Bacterial Brain Abscesses

TL;DR: Through its ability to attenuate excessive inflammation and accelerate abscess encapsulation, ciglitazone may effectively sequester brain abscesses and limit bacterial dissemination.